Skip to main content

Table 3 Assigned treatment doses received and corticosteroid administration from day 0 to day 7

From: Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial

 

UC-MSCs (n = 21)

Placebo (n = 24)

Number of doses received over 7 days

2.7 (0.6)

2.7 (0.5)

 One

2 (9.5%)

1 (4.2%)

 Two

2 (9.5%)

4 (16.7%)

 Three

17 (81%)

19 (79.2%)

Corticosteroids administered for 7 days

15 (71.4%)

19 (79.2%)

  1. Values are expressed as number (%)
  2. UC-MSCs umbilical cord-derived mesenchymal stromal cells